Carcinogenesis, Vol. 20, No. 7, 1315-1321,
July 1999
© 1999 Oxford University Press
Carcinogenesis |
Oxazepam is mutagenic in vivo in Big Blue® transgenic mice
Institute for Environmental Studies, Louisiana State University, Baton Rouge, LA 70803, USA,
1 Centre for Environmental Health, University of Victoria, Victoria, BC V8W 3N5, Canada and
2 Environmental Toxicology Program, National Institute of Environmental Health Sciences, PO Box 12233, Research Triangle Park, NC 27709, USA
Although oxazepam (Serax®), a widely used benzodiazepine anxiolytic, does not induce gene mutations in vitro or chromosomal aberrations in vivo, it was found to be a hepatocarcinogen in a 2 year bioassay in B6C3F1 mice. Thus, it was of interest to determine whether this carcinogen is mutagenic in vivo. Male B6C3F1 Big Blue® transgenic mice were fed 2500 p.p.m. oxazepam or control diet alone for 180 days and killed on the next day. The mutant frequency (MF) of lacI in control mice was 5.02 ± 2.4x105, whereas the MF in the oxazepam-treated mice was 9.17 ± 4.82x10–5, a significant increase (P < 0.05). Correction of the mutant frequency of lacI from the oxazepam-treated mice for clonality resulted in a decrease in the mean mutant frequency to 8.15 ± 2.54x10–5. Although the mutant frequency difference was small, sequencing of a random collection of the mutants from each oxazepam-exposed mouse showed a significant difference (P < 0.015) in the mutation spectrum compared with that from control mice. In the oxazepam-exposed mice, an increase in G:C
T:A and G:CC:G transversions and a concomitant decrease in G:CA:T transitions were observed. Clonal expansion of mutations at guanines in 5'-CpG-3' sequencing contexts at three sites was noted. It is postulated that some of the mutations found in the oxazepam-derived spectrum were due to oxidative damage elicited by induction of CYP2B isozymes as the result of chronic oxazepam administration. This study demonstrates that the in vivo Big Blue® transgenic rodent mutation assay can detect mutations derived from a carcinogen that did not induce gene mutations in vitro or micronuclei in mouse bone marrow. Moreover, the sequencing of the recovered mutants can distinguish between the mutation spectrum from treated mice compared with that from control mice, thereby confirming the genotoxic consequences.
Abbreviations: DMN, dimethylnitrosourea; ENU, ethylnitrosourea; MF, mutant frequency; NTP, National Toxicology Program.
3 To whom correspondence should be addressed Email: cunning1{at}niehs.nih.gov
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. A. Ross, T. Moore, and S. A. Leavitt In vivo mutagenicity of conazole fungicides correlates with tumorigenicity Mutagenesis, March 1, 2009; 24(2): 149 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Iida, C. H. Anna, J. Hartis, M. Bruno, B. Wetmore, J. R. Dubin, S. Sieber, L. Bennett, M. L. Cunningham, R. S. Paules, et al. Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643 Carcinogenesis, April 1, 2003; 24(4): 757 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Deutsch, A. Kukreja, B. Shane, and V. Hegde Phenobarbital, oxazepam and Wyeth 14,643 cause DNA damage as measured by the Comet assay Mutagenesis, September 1, 2001; 16(5): 439 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Stuart, Y. Oda, J. G. de Boer, and B. W. Glickman Mutation Frequency and Specificity With Age in Liver, Bladder and Brain of lacI Transgenic Mice Genetics, March 1, 2000; 154(3): 1291 - 1300. [Abstract] [Full Text]
|
|